Plasma concentrations of intestinal fatty acid binding protein (I-FABP), LPS, and intestinal-targeted pro-inflammatory Th17 cells were found to be significantly increased in hypertensive patients, indicating increased intestinal inflammation and permeability, suggesting that intestinal barrier dysfunction and microbiome function are associated with human hypertension. The gene discussed is FABP2; the disease is hypertensive disorder.